Canada Lung Cancer Market Analysis


  • Type: Oncology area
  • Published : April 2021
  • Region: North America
  • Country: Canada
  • Report ID : 3030

  • Format: PPT, PDF

Canada Lung Cancer Therapeutics Market: Segmented by Treatment Type (Chemotherapy, Radiotherapy, Surgery, and Other Drugs), Cancer Type (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), and by Distribution channel (Hospital Pharmacies, Clinics, Ambulatory Surgical Centres, Retail and Online pharmacies) – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 3030 Categories: ,

Report Overview

Canada’s Lung Cancer Therapeutics market size stood at around USD XX billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of X.X% during the forecast period.

Canada’s lung cancer therapeutics market is expected to grow significantly over the forecast period. In Canada, Lung cancer is the leading cause of cancer deaths for both males (25.2% of cancer deaths) and females (26.1% of cancer deaths). In Canada, lung cancer accounts for 13% of all new cancer cases & 25% of deaths due to cancer. and It is estimated that nearly 29,300 Canadians will develop lung cancer in 2019 and 21,000 will die from it. The incidence of lung cancer remains higher in males (66.0 per 100,000) than females (59.6 per 100,000). Smoking is thought of as the main cause of lung cancer, though lung cancer also follows in non-smokers.

Market Driving Factors

The driving factors for the growth of the Lung Cancer Therapeutics market in Canada include rising prevalence, increasing patient alertness, persistent investment in R&D, and greater adoption of sophisticated and advanced therapies. Growth in the lung cancer therapeutics market can also be attributed to patient’s constant contact with radiation and carcinogens. Furthermore, the late advent of disease symptoms leads to postponement in diagnosis and progression in the cancer stage, which results in the rising cost of the treatment. Increasing adoption and demand for targeted therapies, which is considered to be the foundation of precision medicine is one of the most prominent driving factors for the growth of Canada’s Lung Cancer Therapeutics Market.

1. Canada Lung Cancer Therapeutics Market Overview………………………………
A. Market Size
2. Market Driving and Restraining Factors………………………………….………….
a. Rising prevalence
b. Increasing patient alertness
c. Persistent investment in R&D
d. Greater adoption of sophisticated and advanced therapies
3. Lung Cancer Stages
A. Stage I
B. Stage II
C. Stage III
D. Stage IV
4. Lung Cancer Therapeutics Market Segmentation…………………………………
A. By Treatment Type
a. Chemotherapy
b. Radiotherapy
c. surgery
d. Other Drugs
B. By Cancer Type
a. Non-Small Cell Lung Cancer (NSCLC)
b. Small Cell Lung Cancer (SCLC)
C. By Distribution Channel
a. Hospital pharmacies
b. Clinics
c. Ambulatory Surgical Centres
d. Retail and Online pharmacies
5. Lung Cancer Major Products Market Share………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Boehringer Ingelheim Company overview, Product & Services, Strategies & Financials
B. Astra Zenca Company overview, Product & Services, Strategies & Financials
C. Roche Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of Dermatology drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Treatment Type:

Canada’s Lung cancer therapeutics market can be segmented based on treatment type as Chemotherapy, Radiotherapy, surgery, and Other Drugs. The chemotherapy and minimally invasive surgeries segment which is a subtype of surgeries is expected to grow at the highest CAGR during the forecast period. Fewer incisions, fewer hospital stays, and faster recovery are the major factors that are expected to fuel the growth of the minimally invasive surgeries segment.

By Cancer Type:

Based on the cancer type, the market is segmented into the Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC), where NSCLC leads 85% of the total share. The words small and non-small reference the size of the cells found in the tumor and not the size of the tumor itself.

By Distribution Channel:

Canada’s lung cancer market can be segmented based on its distribution channel into Hospital Pharmacies, Clinics, Ambulatory Surgical Centres, Retail Pharmacies, and Online pharmacies. The hospitals & clinics segment is forecasted to control a massive share in the end-user segment through the forecast period.

Major Players

In Canada Majority of the lung cancer therapeutics are being manufactured by global key players. Recently Takeda Canada Inc. has announced that Health Canada has issued approval for ALUNBRIG® (brigatinib tablets) as monotherapy for the first-line treatment of adult patients with anaplastic lymphoma kinase positive (ALK+) locally advanced or metastatic non-small cell lung cancer (NSCLC).

Roche Canada has also announced that its medicine Tecentriq® (atezolizumab) got Health Canada approval to use in combination with carboplatin & etoposide for the first-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC), representing the first new treatment for the disease in more than two decades. Tecentriq is the first and only approved cancer immunotherapy agent in Canada for first-line SCLC.

Other Major Players are Boehringer Ingelheim, Astra Zenca, Pfizer, Eli Lilly and Company.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements